Corebridge Financial Inc. Sells 5,249 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Corebridge Financial Inc. cut its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 141,959 shares of the company’s stock after selling 5,249 shares during the period. Corebridge Financial Inc.’s holdings in GE HealthCare Technologies were worth $11,098,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Cathy Pareto & Associates Inc. acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at $670,000. Principal Financial Group Inc. increased its position in GE HealthCare Technologies by 1.9% in the 3rd quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company’s stock valued at $94,780,000 after acquiring an additional 19,010 shares in the last quarter. Everence Capital Management Inc. raised its stake in shares of GE HealthCare Technologies by 118.2% in the fourth quarter. Everence Capital Management Inc. now owns 18,870 shares of the company’s stock worth $1,475,000 after acquiring an additional 10,220 shares during the last quarter. Nomura Asset Management Co. Ltd. lifted its position in shares of GE HealthCare Technologies by 9.7% during the third quarter. Nomura Asset Management Co. Ltd. now owns 145,996 shares of the company’s stock worth $13,702,000 after purchasing an additional 12,908 shares in the last quarter. Finally, Apollon Wealth Management LLC grew its stake in shares of GE HealthCare Technologies by 46.5% during the fourth quarter. Apollon Wealth Management LLC now owns 13,111 shares of the company’s stock valued at $1,025,000 after purchasing an additional 4,160 shares during the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Down 1.8 %

GE HealthCare Technologies stock opened at $81.00 on Thursday. The firm has a market capitalization of $37.04 billion, a price-to-earnings ratio of 18.71, a PEG ratio of 3.19 and a beta of 1.13. The company’s 50 day simple moving average is $86.86 and its 200 day simple moving average is $85.93. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. GE HealthCare Technologies Inc. has a fifty-two week low of $74.51 and a fifty-two week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. The company had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. As a group, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

Analysts Set New Price Targets

GEHC has been the subject of several research analyst reports. Wells Fargo & Company boosted their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and upped their price target for the company from $85.00 to $100.00 in a research note on Tuesday, March 11th. Citigroup lifted their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. Finally, Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their target price for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $98.75.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.